ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
HeartBeam Inc

HeartBeam Inc (BEAT)

2,39
-0,03
(-1,24%)
Beim Schlusskurs: 25 Dezember 10:00PM
2,39
0,00
( 0,00% )
Nach Börsenschluss: 11:00PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
2,39
Gebot
2,16
Fragen
2,49
Volumen
25.668
2,3501 Tagesbereich 2,4899
1,35 52-Wochen-Bereich 3,3893
Marktkapitalisierung
Handelsende
2,42
Handelsbeginn
2,45
Letzte Trade
40
@
2.49
Letzter Handelszeitpunkt
22:09:42
Finanzvolumen
US$ 61.920
VWAP
2,4123
Durchschnittliches Volumen (3 Mio.)
154.574
Ausgegebene Aktien
26.665.470
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,35
Gewinn pro Aktie (EPS)
-0,55
Erlöse
-
Nettogewinn
-14,64M

Über HeartBeam Inc

HeartBeam Inc is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Its initial focus is providing diagnostic data to help physicians with care management of patients with cardio... HeartBeam Inc is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Its initial focus is providing diagnostic data to help physicians with care management of patients with cardiovascular disease. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
HeartBeam Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker BEAT. The last closing price for HeartBeam was US$2,42. Over the last year, HeartBeam shares have traded in a share price range of US$ 1,35 to US$ 3,3893.

HeartBeam currently has 26.665.470 shares in issue. The market capitalisation of HeartBeam is US$64,53 million. HeartBeam has a price to earnings ratio (PE ratio) of -4.35.

BEAT Neueste Nachrichten

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia assessment The Company is gearing up for an Early Access Program to gain initial...

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

First cable-free, ambulatory ECG that captures the heart’s electrical signals from three distinct directions for high-fidelity data collection and advanced diagnostics Patients can have the...

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

The studies further strengthen HeartBeam’s body of clinical evidence for its portable, cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead ECG The first...

HeartBeam Reports Third Quarter 2024 Results

Continued Clinical and Regulatory Progress on the HeartBeam System Key Appointments to Management Team Completed as Part of Planned Evolution in Preparation for US Commercialization...

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, will hold a conference call on...

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Company Receives Top Honors in the ‘Home Health Diagnostic’ Category for its Groundbreaking Technology that Captures the Heart’s Electrical Signals from Three Dimensions HeartBeam, Inc. (NASDAQ:...

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and delivering growth Founder and current CEO Branislav Vajdic named President to...

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Industry Leader, Former Head of Data Science at Verily (Google Life Sciences) and Globally Respected Authority on Artificial Intelligence (AI) Applications in Biosensor Technologies Dr. Myers to...

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

Seasoned MedTech Leader with Proven Track Record of Strategic Planning, Financial Stewardship and Commercial Success HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on...

HeartBeam Reports Second Quarter 2024 Results

Continued Clinical and Regulatory Progress on the HeartBeam AIMIGo™ System Enrollment Complete in VALID-ECG Clinical Study That Will Be the Basis of the Upcoming FDA Submission on the 12-Lead...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.275-10.31894934332.6652.822.321607602.5471303CS
4-0.43-15.24822695042.823.352.282785142.77191139CS
120.052.136752136752.343.352.061545742.63372274CS
26-0.01-0.4166666666672.43.3521109812.59011541CS
520.2712.73584905662.123.38931.351306402.3734271CS
156-1.06-30.72463768123.456.741.064871852.87226204CS
260-44.86-94.941798941847.2573.11.0639896915.84420257CS

BEAT - Frequently Asked Questions (FAQ)

What is the current HeartBeam share price?
The current share price of HeartBeam is US$ 2,39
How many HeartBeam shares are in issue?
HeartBeam has 26.665.470 shares in issue
What is the market cap of HeartBeam?
The market capitalisation of HeartBeam is USD 64,53M
What is the 1 year trading range for HeartBeam share price?
HeartBeam has traded in the range of US$ 1,35 to US$ 3,3893 during the past year
What is the PE ratio of HeartBeam?
The price to earnings ratio of HeartBeam is -4,35
What is the reporting currency for HeartBeam?
HeartBeam reports financial results in USD
What is the latest annual profit for HeartBeam?
The latest annual profit of HeartBeam is USD -14,64M
What is the registered address of HeartBeam?
The registered address for HeartBeam is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the HeartBeam website address?
The website address for HeartBeam is www.heartbeam.com
Which industry sector does HeartBeam operate in?
HeartBeam operates in the SURGICAL,MED INSTR,APPARATUS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ADDColor Star Technology Company Ltd
US$ 3,56
(64,81%)
307,74k
GVVisionary Holdings Inc
US$ 2,17
(48,63%)
139,91k
AIXIXIAO I Corporation
US$ 7,24
(34,82%)
33,51k
LICNLichen China Limited
US$ 0,27
(28,51%)
1,87M
FEAM5E Advanced Materials Inc
US$ 0,4918
(13,03%)
3,08k
SVRESaverOne 2014 Ltd
US$ 1,04
(-31,13%)
13,54k
NEUPNeuphoria Therapeutics Inc
 5,02
(-24,28%)
6,88k
HOURHour Loop Inc
US$ 3,40
(-22,73%)
78,26k
CREVCarbon Revolution Public Ltd
US$ 7,10
(-22,49%)
35,55k
BAOSBaosheng Media Group Holdings Ltd
US$ 5,62
(-20,85%)
112,8k
LICNLichen China Limited
US$ 0,27
(28,51%)
1,87M
SVMHSRIVARU Holding Ltd
US$ 0,0345
(2,07%)
1,06M
XTIAXTI Aerospace Inc
US$ 0,0397
(1,28%)
558,34k
CEROCERo Therapeutics Holdings Inc
US$ 0,0605
(-2,89%)
489,82k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,3889
(0,93%)
453,03k
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock